Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1461 of 6351
-
New inhaled insulin combo aims to simplify diabetes care for teens
Disease control Recruiting nowINHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 6 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also eva…
Phase 2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Spray shield: new hope against radiation burns
Prevention CancelledRadiotherapy always results in many complications such as radiation dermatitis,dry mouth, cranial nerve damage, and swallowing function. Among them,radiation dermatitis is confirmed to occur in the majority of tumor patientsreceiving radiotherapy, which not only affects the appea…
Sponsor: West China Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
New suction device aims to clear dangerous leg clots
Disease control Recruiting nowThe primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of thrombus in patients with lower extremity proximal deep vein thrombosis (DVT). This prospective, multi-center, open-label …
Sponsor: Argon Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could CAR-T cells tame severe colitis? early trial launches
Disease control Recruiting nowA Single-Center, Open-Label, Single-Arm Exploratory Clinical Study on the Use of Autologous CAR-T Cell Therapy Injection for the Treatment of Refractory and Relapsing Ulcerative Colitis: A Preliminary Exploration of 12-Week Clinical Remission with Autologous CAR-T Cell Injection …
Early phase 1 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could some AML patients ditch chemo pills after a year?
Disease control Recruiting nowThe goal of this clinical trial is to test efficacy and safety of a VENETOCLAX-AZACITIDINE (VEN-AZA) de-escalation strategy in Acute Myeloid Leukemia responding patients. The main objectives of the study are: * Evaluation of the efficacy of VEN-AZA de-escalation strategy by meas…
Phase 2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo aims to tame Graft-Versus-Host disease in older blood cancer patients
Disease control Recruiting nowThis phase II trial tests the effect of adding ruxolitinib to standard graft versus host disease (GVHD) prevention in treating older patients with myelofibrosis (MF) or myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes before, during, and after a do…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Head-to-Head: which EoE drug fights scarring better?
Disease control By invitation onlyThe purpose of this study is to compare Eosinophilic Esophagitis treatments Eohilia with Dupixent in their effects on diameter and scarring of the esophagus.
Early phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New lung implant could help severe emphysema patients breathe easier
Disease control Recruiting nowA Study at Two Hospitals Testing the Safety and Effectiveness of the IAB 50 Flex, a New Implant for Adults with Severe COPD or Emphysema
Sponsor: Pulmair Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Hospital stay no longer means losing independence: new study tests exercise and nutrition strategy
Disease control Not yet recruitingAproximately a third of persons older than 70 years lose physical function and ability to take care of themselves during a stay at a hospital. This is associated to an increased risk of readmission and mortality. Earlier research has shown that insufficient nutrition and physical…
Sponsor: Bispebjerg Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental CAR-T therapy targets tough autoimmune blood diseases
Disease control Recruiting nowThis is a single-arm, open-label, investigator-initiated trial (IIT) designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of RD06-05 in subjects with autoantibody-mediated autoimmune hematological diseases. The enrolled populat…
Early phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Experimental gene injection aims to save sight in rare retinal disorder
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of PUMCH-E111 injection in subjects with RLBP1 related Inherited Retinal Dystrophy.
Early phase 1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
The hidden danger in your legs: could asymmetry predict falls?
Knowledge-focused Recruiting nowFalls among older adults represent a major public health burden. Approximately 30% of individuals aged 65 and older experience at least one fall each year. These events can lead not only to increased anxiety, depression, and reduced quality of life but also to serious injuries or…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Beyond the pelvis: could hip and leg alignment hold clues to stress incontinence?
Knowledge-focused Recruiting nowStress urinary incontinence (SUI) in postmenopausal women is traditionally considered a local pelvic floor disorder, but emerging evidence suggests that spinopelvic and lower limb alignment may also contribute to continence mechanisms. Transperineal ultrasound α/β angles and post…
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New pill could soothe severe eczema – trial underway
Disease control Recruiting nowThis clinical trial aims to explore whether the drug ZL-82 tablets can be used to treat moderate to severe atopic dermatitis in adults, and to understand the safety and tolerability of the drug. The main questions that the trial intends to answer are: Can ZL-82 tablets alleviate …
Phase 2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could two common drugs stop Opioid-Induced nausea in cancer patients?
Prevention Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of olanzapine plus metoclopramide in preventing opioid-induced nausea and vomiting (OINV) in adult patients with advanced cancer who are initiating strong opioid therapy. The main questions it aims to answer a…
Phase 3 • Sponsor: Affiliated Hospital of Qinghai University • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
New drug could stop knee infections after replacement
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether the investigational drug PLG0206 can help reduce recurrence of infection in adults who have undergone total knee replacement and are receiving a DAIR (Debridement, Antibiotics, and Implant Retention) surgical procedure to tre…
Phase 2/3 • Sponsor: Peptilogics • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New trial aims to improve radiation for large brain tumors
Disease control Recruiting nowThis is a randomized, phase II trial comparing staged stereotactic radiosurgery (SSRS) versus fractionated stereotactic radiotherapy (FSRT) in patients with large brain metastases (≥2 cm and ≤5 cm). The study aims to evaluate efficacy, safety, and tumor response between these two…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Simple blood test could spot three cancers before symptoms appear
Diagnosis Recruiting nowThe goal of this clinical trial is to develop a new cancer diagnostic and prognostic tool based on the dynamic and non-invasive detection of an exogenous volatile molecule, i.e., ethanol, from patients' samples. Patients' blood plasma will be analyzed with a mixture of volatile …
Early phase 1 • Sponsor: Poitiers University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
New combo therapy targets tough lung cancer in early trial
Disease control Recruiting nowThe purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refractory Small Cell Lung Cancer
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New pill could tame Flare-Ups for ulcerative colitis patients
Disease control Recruiting nowThe purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC